Michelle Teplensky

Dr. Michelle Teplensky is an Assistant Professor in Biomedical Engineering and Materials Science at Boston University, where she directs research on nanomaterial-based immune engineering. Her lab develops nanoparticle platforms for next-generation vaccines and cancer immunotherapies.

Research integrates nanotechnology with immunology to create programmable biomaterials that control immune cell interactions. Recent publications focus on:

• Spherical nucleic acid vaccine architectures
• Metal-organic frameworks for drug delivery
• Tumor microenvironment modulation
• Multi-antigen vaccine optimization

Awards include the Beckman Young Investigator Award and AIChE 35 Under 35 recognition for innovations in nanovaccine design.